The Nordic region is a potentially lucrative area for medical device companies to expand into, with analyst research estimating Sweden alone to have a 2.7% market sh...

Prescription drug insurance in Canada is provided by a mixture of government and private plans. Government plans offer coverage to about a quarter of the population ...

Late last year, visionaries from Merck, Syneos Health and Accenture took part in a live video debate on what now influences the way life sciences companies manage Qu...

Ben Wylie at ChargePoint Technology looks back on key learnings from 2021 for cleanroom pharmaceutical manufacturing. He explores why flexibility is key to overcomin...

Across Asia, pharma leaders are working hard to accelerate their Industry 4.0 digital transformation and, in the process, ensure current Good Practice (cGXP) complia...

In life sciences, research, advances in instrumentation, new types of measurements that are now possible and improved computational tools are generating not only sig...

Gastric cancer is the fifth most common cancer, with around one million annual incidences worldwide, and it represents the fourth most common cause of cancer deaths....

Traditionally, most marketed drugs, irrespective of their route of delivery, have had relatively low molecular weights. Nowhere has this been more markedly true than...

In recent years, a consensus has grown around the concern that clinical trials in the United States are neither adequately inclusive nor diverse. For example, the la...

Decentralised clinical trials (DCTs) have existed for years in different shapes and forms. Urged by the COVID-19 pandemic, restrictions to in-person patient visits a...